Eva Hilger

1.5k total citations
35 papers, 948 citations indexed

About

Eva Hilger is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Clinical Psychology. According to data from OpenAlex, Eva Hilger has authored 35 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Clinical Psychology. Recurrent topics in Eva Hilger's work include Circadian rhythm and melatonin (7 papers), Tryptophan and brain disorders (7 papers) and Schizophrenia research and treatment (5 papers). Eva Hilger is often cited by papers focused on Circadian rhythm and melatonin (7 papers), Tryptophan and brain disorders (7 papers) and Schizophrenia research and treatment (5 papers). Eva Hilger collaborates with scholars based in Austria, Germany and United States. Eva Hilger's co-authors include Siegfried Kasper, Alexander Neumeister, Matthäus Willeit, N. Praschak-Rieder, J. Stastny, Anastasios Konstantinidis, S. Asenbaum, Walter Pirker, Fritz Zimprich and Katharina Leithner and has published in prestigious journals such as PLoS ONE, Neurology and Scientific Reports.

In The Last Decade

Eva Hilger

34 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Hilger Austria 18 252 238 182 147 141 35 948
Cathrin Rohleder Germany 19 184 0.7× 261 1.1× 102 0.6× 469 3.2× 159 1.1× 43 1.0k
Amna Zehra United States 9 107 0.4× 325 1.4× 201 1.1× 153 1.0× 364 2.6× 10 979
Primavera A. Spagnolo United States 21 152 0.6× 321 1.3× 51 0.3× 264 1.8× 327 2.3× 41 1.2k
Kenneth N. Sokolski United States 16 341 1.4× 120 0.5× 50 0.3× 97 0.7× 101 0.7× 27 627
Wilfrid N. Raby United States 19 149 0.6× 363 1.5× 170 0.9× 252 1.7× 125 0.9× 29 898
Saliha Özsoy Türkiye 16 225 0.9× 83 0.3× 164 0.9× 68 0.5× 69 0.5× 47 796
Terrence Sills Canada 20 317 1.3× 381 1.6× 86 0.5× 141 1.0× 141 1.0× 36 968
Bernadette M. Cortese United States 16 204 0.8× 224 0.9× 47 0.3× 45 0.3× 280 2.0× 35 1.0k
E. R�ther Germany 14 238 0.9× 124 0.5× 73 0.4× 82 0.6× 253 1.8× 20 832
Jarmila Hallman Sweden 18 106 0.4× 250 1.1× 175 1.0× 67 0.5× 88 0.6× 29 824

Countries citing papers authored by Eva Hilger

Since Specialization
Citations

This map shows the geographic impact of Eva Hilger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Hilger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Hilger more than expected).

Fields of papers citing papers by Eva Hilger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Hilger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Hilger. The network helps show where Eva Hilger may publish in the future.

Co-authorship network of co-authors of Eva Hilger

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Hilger. A scholar is included among the top collaborators of Eva Hilger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Hilger. Eva Hilger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rath, Jakob, Gudrun Zulehner, Eva Hilger, et al.. (2019). Frequency and clinical features of treatment-refractory myasthenia gravis. Journal of Neurology. 267(4). 1004–1011. 23 indexed citations
2.
Rath, Jakob, Matthias Mauritz, Gudrun Zulehner, et al.. (2017). Iodinated contrast agents in patients with myasthenia gravis: a retrospective cohort study. Journal of Neurology. 264(6). 1209–1217. 4 indexed citations
3.
Hilger, Eva, Fritz Zimprich, Ekaterina Pataraia, et al.. (2016). Psychoses in epilepsy: A comparison of postictal and interictal psychoses. Epilepsy & Behavior. 60. 58–62. 27 indexed citations
4.
Leithner, Katharina, Andrea Naderer, Johanna Alexopoulos, et al.. (2015). Sexual and Psychosocial Functioning in Women with MRKHS after Neovaginoplasty According to Wharton-Sheares-George: A Case Control Study. PLoS ONE. 10(4). e0124604–e0124604. 16 indexed citations
5.
Hilger, Eva, Eva M. Reinthaler, Elisabeth Stögmann, et al.. (2012). Lack of Association Between ABCC2 Gene Variants and Treatment Response in Epilepsy. Pharmacogenomics. 13(2). 185–190. 32 indexed citations
6.
Schreinzer, D., Werner Brannath, Thomas Lang�, et al.. (2005). Components of behavioral pathology in dementia. International Journal of Geriatric Psychiatry. 20(2). 137–145. 24 indexed citations
7.
Fischer‐Kern, Melitta, Katharina Leithner, Eva Hilger, Henriette Löffler‐Stastka, & Peter Schuster. (2004). Context‐Oriented Model Development in Psychotherapy Planning (‘COMEPP’): a useful adjunct to diagnosis and therapy of severe personality disorders. Acta Psychiatrica Scandinavica. 109(3). 235–238. 1 indexed citations
8.
Willeit, Matthäus, N. Praschak-Rieder, Alexander Neumeister, et al.. (2003). A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Molecular Psychiatry. 8(11). 942–946. 88 indexed citations
9.
Hilger, Eva, Christian Barnas, & Siegfried Kasper. (2003). Quetiapine in the Treatment of Borderline Personality Disorder. The World Journal of Biological Psychiatry. 4(1). 42–44. 29 indexed citations
10.
Thierry, Nikolaus, Matthäus Willeit, N. Praschak-Rieder, et al.. (2003). Serotonin transporter promoter gene polymorphic region (5-HTTLPR) and personality in female patients with seasonal affective disorder and in healthy controls. European Neuropsychopharmacology. 14(1). 53–58. 17 indexed citations
11.
Hilger, Eva & Siegfried Kasper. (2002). Kognitive Symptomatik bei schizophrener Erkrankung: Diagnostik und Pharmakotherapie. Journal für Kardiologie (Krause & Pachernegg GmbH). 3(4). 17–22. 3 indexed citations
12.
Konstantinidis, Anastasios, J. Stastny, Eva Hilger, et al.. (2002). Intravenous mirtazapine in the treatment of depressed inpatients. European Neuropsychopharmacology. 12(1). 57–60. 9 indexed citations
13.
Winkler, Dietmar, Matthäus Willeit, N. Praschak-Rieder, et al.. (2002). Changes of clinical pattern in seasonal affective disorder (SAD) over time in a German-speaking sample. European Archives of Psychiatry and Clinical Neuroscience. 252(2). 54–62. 27 indexed citations
14.
Winkler, Dietmar, N. Praschak-Rieder, Matthäus Willeit, et al.. (2002). Saisonal abhängige Depression in zwei deutschsprachigen Universitätszentren: Bonn, Wien Klinische und demographische Charakteristika. Der Nervenarzt. 73(7). 637–643. 13 indexed citations
15.
Neumeister, Alexander, Matthäus Willeit, N. Praschak-Rieder, et al.. (2001). Dopamine transporter availability in symptomatic depressed patients with seasonal affective disorder and healthy controls. Psychological Medicine. 31(8). 1467–1473. 82 indexed citations
16.
Barnas, Christian, J. Tauscher, Eva Hilger, et al.. (2001). In vivo 123I IBZM SPECT imaging of striatal dopamine 2 receptor occupancy in schizophrenic patients. Psychopharmacology. 157(3). 236–242. 12 indexed citations
17.
Kasper, Siegfried, et al.. (2000). Reboxetine: the first selective noradrenaline re-uptake inhibitor. Expert Opinion on Pharmacotherapy. 1(4). 771–782. 45 indexed citations
18.
Willeit, Matthäus, N. Praschak-Rieder, Alexander Neumeister, et al.. (2000). [123I]-β-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biological Psychiatry. 47(6). 482–489. 143 indexed citations
19.
Praschak-Rieder, N., Matthäus Willeit, Alexander Neumeister, Eva Hilger, & Siegfried Kasper. (1999). [Therapeutic sleep deprivation and phototherapy].. PubMed. 149(18). 520–4. 8 indexed citations
20.
Hilger, Eva, Matthäus Willeit, N. Praschak-Rieder, et al.. (1999). Rapid remission of atypical depressive symptoms with the selective noradrenalin reuptake inhibitor reboxetine in SAD patients. European Neuropsychopharmacology. 9. 243–243. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathrin Rohleder Breakdown of academic impact, for papers by Amna Zehra Breakdown of academic impact, for papers by Primavera A. Spagnolo Breakdown of academic impact, for papers by Kenneth N. Sokolski Breakdown of academic impact, for papers by Wilfrid N. Raby Breakdown of academic impact, for papers by Saliha Özsoy Breakdown of academic impact, for papers by Terrence Sills Breakdown of academic impact, for papers by Bernadette M. Cortese Breakdown of academic impact, for papers by E. R�ther Breakdown of academic impact, for papers by Jarmila Hallman
Rankless by CCL
2026